<DOC>
	<DOCNO>NCT02316847</DOCNO>
	<brief_summary>This study assess long-term safety tolerability repeat dose diazepam nasal spray adolescent adults cluster seizure , focus potential local effect ( change nasal mucosa , olfaction , taste ) .</brief_summary>
	<brief_title>An Open-Label , Safety Tolerability Study Chronic Intermittent Use Diazepam Nasal Spray Adolescents Adults With Cluster Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<criteria>Diagnosis drugresistant epilepsy Patients experience multiple episode acute repetitive seizure require least one concomitant antiepileptic drug ( AED ) Occurrence least 3 seizure cluster within past 12 month , include least one cluster 4 month prior Screening Visit A caregiver must consent participate together subject purpose observation data collection The caregiver must present investigational product administer Screening body weight 26 111 kg , inclusive Female subject pregnant , breastfeeding , plan become pregnant Presence history abnormality illness may affect absorption , distribution , metabolism elimination diazepam Known allergy hypersensitivity diazepam , related drug , formulation component Positive screen test ethanol drug abuse Unable receive medication intranasally</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cluster Seizures</keyword>
	<keyword>Seizures</keyword>
	<keyword>Clusters</keyword>
	<keyword>Acute repetitive seizure</keyword>
</DOC>